In vitro, calpain-1 cleaves both wildtype and PD mutant forms of fibrillar α-synuclein within the C-terminus (Mishizen-Eberz et al., 2003; Diepenbroek et al., 2014), which may increase the aggregating potential of α-synuclein. This evidence concerns the gene SNCA and Parkinson disease.